Expert Analysis - Opinion

Gilead Ruling Signals That Innovating Can Lead To Liability

By Gary Myers · February 6, 2024, 5:15 PM EST

The Court of Appeal of the State of California ruled last month that a drug manufacturer can be liable for negligence for its delay in introducing an improved version of its...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

ERISA Recap: 4 Rulings Worth Paying Attention To From Nov. No Photo Available

Kellie Mejdrich

The Ninth Circuit striking down a class action win for transgender employee health plan participants who said their gender-affirming c... (more story)

CDC Panel Ends Recommendation Of Hepatitis B Shot At Birth No Photo Available

Yeji Jesse Lee

A panel of federal vaccine advisers on Friday voted to lift a long-standing recommendation that all newborns be given vaccinations for hepatitis B.

Lawyers Adapt To Crop Of New FDA Pilots No Photo Available

Yeji Jesse Lee

A slew of new FDA pilot programs is forcing life science attorneys to adjust to a new reality of programs that shed bureaucratic proce... (more story)